The Emergency Care of Patients with Cancer: Setting the Research Agenda, Ann Emerg Med, vol.68, pp.706-717, 2016. ,
Management of febrile neutropenia in an acute oncology service, QJM, vol.105, pp.327-363, 2012. ,
Time to antibiotics and outcomes in cancer patients with febrile neutropenia, BMC Health Serv Res, vol.14, p.162, 2014. ,
Risk factors associated with complications in patientswith chemotherapy-induced febrile neutropenia in emergency department, Hematol Oncol, vol.31, pp.189-96, 2013. ,
Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department, J Oncol Pract, vol.11, pp.450-455, 2015. ,
Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia, Support Care Cancer, vol.23, p.25663578, 2015. ,
Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia ,
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America, Clin Infect Dis, vol.52, pp.56-93, 2011. ,
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the, 4th European Conference on Infections in Leukemia, vol.98, pp.1826-1861, 2011. ,
Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes, JAMA Intern Med, vol.173, pp.559-68, 2013. ,
The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients, J Clin Oncol, vol.18, pp.3038-51, 2000. ,
Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk FebrileNeutropenic Patients in the Emergency Department, Ann Emerg Med, vol.69, pp.755-64, 2017. ,
Multiple imputation: a mature approach to dealing with missing data, Intensive Care Med, vol.41, p.25578679, 2015. ,
Multiple imputation using chained equations: Issues and guidance for practice, Stat Med, vol.30, pp.377-99, 2011. ,
Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines, Clin Infect Dis, vol.66, pp.1631-1636, 2018. ,
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016, Intensive Care Med, vol.43, p.28101605, 2017. ,
European Society of Emergency Medicine position paper on the 1-hour sepsis bundle of the Surviving Sepsis Campaign: expression of concern, Eur J Emerg Med, vol.26, pp.232-235, 2019. ,
Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia, Antimicrob Agents Chemother, vol.58, pp.2561-2575, 2014. ,
Neutropenic cancer patients with severe sepsis: need for antibiotics in the first hour, Intensive Care Med, vol.40, p.24966064, 2014. ,
Improved survival of critically ill cancer patients with septic shock, Intensive Care Med, vol.29, p.13680115, 2003. ,
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update, J Clin Oncol, vol.36, pp.1443-53, 2018. ,
Survival in neutropenic patients with severe sepsis or septic shock, Crit Care Med, vol.40, pp.43-52, 2012. ,
Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance, Clin Infect Dis, 2019. ,
Central venous oxygen saturation is not predictive of early complications in cancer patients presenting to the emergency department, Intern Emerg Med, vol.14, p.30306323, 2019. ,
Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-a groupe de recherche respiratoire en ré animation onco-hématologique study, J Clin Oncol, vol.31, pp.2810-2818, 2013. ,
Managing critically Ill hematology patients: Time to think differently, Blood Rev, vol.29, pp.359-67, 2015. ,
Is shock index a valid predictor of mortality in emergency department patients with hypertension, diabetes, high age, or receipt of ?-or calcium channel blockers?, Ann Emerg Med, vol.67, pp.106-119, 2016. ,
Shock index and early recognition of sepsis in the emergency department: pilot study, West J Emerg Med, vol.14, pp.168-74, 2013. ,
Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia, Support Care Cancer, vol.25, p.28062972, 2017. ,
Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score, Support Care Cancer, vol.12, p.15197637, 2004. ,
Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice, Support Care Cancer, vol.16, p.17899215, 2008. ,
Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients, Support Care Cancer, vol.16, p.17960431, 2008. ,
Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients, Ann Hematol, vol.87, pp.563-572, 2008. ,
Inter-rater reliability of case-note audit: a systematic review, J Health Serv Res Policy, vol.12, pp.173-80, 2007. ,